Banking, Finance & Insurance Global On demand · 24-48h

Global Short Term Health Insurance Market Strategic Research Report

Global Short Term Health Insurance Market Strategic Research…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Short Term Health Insurance Market
$62.05B2025
5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Reimbursement, Payment Method

By Application: Individuals, Enterprises

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: UnitedHealth Group, Elevance Health, Centene Corporation, Cigna Group, Humana, CVS Health, Kaiser Permanente, Allianz, AXA, Zurich Insurance, Bupa, Generali Group, Aviva, Ping An Insurance, China Life Insurance, CPIC, AIA Group, Manulife, Sun Life Financial, Nippon Life, Molina Healthcare, Legal & General, NN Group, Achmea, DKV Mobility, MS&AD Insurance, Sompo Holdings, Prudential Financial, Aflac

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 176 pages
Market size 2025
$62.05B
Billion USD
Forecast CAGR
5%
2025-2032
Forecast 2032
$87.3B
Projected
Régions
5
Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global Short Term Health Insurance market size is predicted to grow from US$ 62,055 million in 2025 to US$ 87,121 million in 2032; it is expected to grow at a CAGR of 5.0% from 2026 to 2032.

Short-term health insurance is an important segment of health insurance. According to regulatory definitions, it refers to health insurance with an insurance period of one year or less and no guaranteed renewal clause, mainly providing short-term medical protection for the insured. It mainly covers medical expenses such as outpatient and hospitalization caused by diseases and accidents for the insured, with flexible and diverse product designs, low insurance thresholds and affordable premiums. It does not require long-term binding, and the insurance period can be flexibly selected according to personal needs, adapting to short-term protection gaps, such as temporary medical needs, social security connection, short-term travel and other scenarios. It is an important choice to supplement long-term health insurance and meet multi-level health protection needs, and also one of the core products with both flexibility and practicality in the global health insurance market.

Against the backdrop of diversified global health protection needs and an increasing number of short-term risk scenarios, short-term health insurance, with its core advantages of flexibility, convenience, and cost-effectiveness, has become a highly dynamic segment of the global health insurance market. It precisely fills various short-term medical protection gaps, providing efficient and flexible health protection for different groups. As an important component of health insurance, short-term health insurance, according to regulatory definitions, has an insurance period of one year or less and no guaranteed renewal clause. Focusing on short-term medical protection, it serves as an important supplement to the comprehensive global multi-tiered healthcare system.

Currently, with the continuous rise in global medical costs, diverse needs such as temporary medical treatment, short-term travel, social security integration, and phased protection are becoming increasingly prominent, highlighting the value of short-term health insurance. Unlike long-term health insurance, which is tied to long-term coverage, short-term health insurance products are flexible and diverse in design, with low entry barriers and affordable premiums. Coverage periods ranging from one month to one year can be flexibly chosen according to individual needs. No complex health declarations are required, the application process is convenient, and it broadly covers various groups, including children, adults, and the elderly. It is particularly suitable for those with limited budgets and temporary protection needs, quickly filling protection gaps.

From the perspective of core product advantages, short-term health insurance focuses on core medical protection, primarily covering medical expenses such as outpatient, inpatient, and surgical costs caused by illness or accidents. Some products offer flexible add-ons such as critical illness allowances and hospitalization allowances, precisely matching the needs of different scenarios. Leading global institutions such as UnitedHealth Group, Ping An Insurance, and AIA are focusing on short-term protection scenarios, continuously optimizing product structures and enriching service content, driving the transformation of short-term health insurance from "basic payouts" to "protection + services," integrating value-added services such as remote consultations, medical accompaniment, and health education to enhance product competitiveness and customer experience.

Technological innovation is injecting new vitality into the short-term health insurance market. Global insurance companies leverage big data and artificial intelligence technologies to accurately analyze short-term health risk characteristics, optimize pricing and underwriting processes, and achieve one-click insurance and convenient claims, significantly improving service efficiency. Simultaneously, scenario-based product innovation continues to advance, launching customized products for different groups and scenarios such as short-term business trips, tourism, students, and freelancers, further expanding market coverage.

From a global market perspective, North America and Europe, with their mature commercial insurance systems, boast high penetration rates and sophisticated product iterations in short-term health insurance. The Asia-Pacific region, as a core growth engine, sees continued demand from countries like China and India, leading to accelerated product innovation. Emerging markets, with their improving healthcare infrastructure, are gradually becoming new drivers of market growth. Looking ahead, as the demand for short-term health protection continues to upgrade and product scenario-based innovation deepens, short-term health insurance will continue to leverage its flexibility and convenience, becoming a significant growth engine in the global health insurance market. It will safeguard the short-term health needs of various population groups, offering vast market potential and promising development prospects.

This report presents a comprehensive overview of the global Short Term Health Insurance market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Reimbursement
  • Payment Method

Segment by Beneficiaries

  • Children
  • Adults

Segment by Coverage Scope

  • Medical Insurance
  • Critical Illness Insurance
  • Others

Segment by Application

  • Individuals
  • Enterprises

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Short Term Health Insurance market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Individuals, Enterprises evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Short Term Health Insurance Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$62.05B
2025
Forecast
$87.3B
2032
CAGR
5%
2025–2032
Régions
5
global
Key companies
UnitedHealth GroupElevance HealthCentene CorporationCigna GroupHumanaCVS HealthKaiser PermanenteAllianz
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
ReimbursementPayment Method
By Application
IndividualsEnterprises

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Reimbursement
  • 3.1.3 Payment Method
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Individuals
  • 4.1.3 Enterprises
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 UnitedHealth Group
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Elevance Health
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Centene Corporation
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Cigna Group
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Humana
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 CVS Health
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Kaiser Permanente
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Allianz
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 AXA
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Zurich Insurance
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Bupa
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Generali Group
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Aviva
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Ping An Insurance
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 China Life Insurance
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 CPIC
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 AIA Group
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Manulife
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Sun Life Financial
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Nippon Life
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Molina Healthcare
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Legal & General
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 NN Group
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
  • 8.24 Achmea
  • 8.24.1 Company Overview
  • 8.24.2 Key Products & Segments
  • 8.24.3 Financial Performance (2023–2025)
  • 8.24.4 Business Strategy
  • 8.24.5 SWOT Analysis
  • 8.24.6 Strategic Implications (2026–2032)
  • 8.25 DKV Mobility
  • 8.25.1 Company Overview
  • 8.25.2 Key Products & Segments
  • 8.25.3 Financial Performance (2023–2025)
  • 8.25.4 Business Strategy
  • 8.25.5 SWOT Analysis
  • 8.25.6 Strategic Implications (2026–2032)
  • 8.26 MS&AD Insurance
  • 8.26.1 Company Overview
  • 8.26.2 Key Products & Segments
  • 8.26.3 Financial Performance (2023–2025)
  • 8.26.4 Business Strategy
  • 8.26.5 SWOT Analysis
  • 8.26.6 Strategic Implications (2026–2032)
  • 8.27 Sompo Holdings
  • 8.27.1 Company Overview
  • 8.27.2 Key Products & Segments
  • 8.27.3 Financial Performance (2023–2025)
  • 8.27.4 Business Strategy
  • 8.27.5 SWOT Analysis
  • 8.27.6 Strategic Implications (2026–2032)
  • 8.28 Prudential Financial
  • 8.28.1 Company Overview
  • 8.28.2 Key Products & Segments
  • 8.28.3 Financial Performance (2023–2025)
  • 8.28.4 Business Strategy
  • 8.28.5 SWOT Analysis
  • 8.28.6 Strategic Implications (2026–2032)
  • 8.29 Aflac
  • 8.29.1 Company Overview
  • 8.29.2 Key Products & Segments
  • 8.29.3 Financial Performance (2023–2025)
  • 8.29.4 Business Strategy
  • 8.29.5 SWOT Analysis
  • 8.29.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Short Term Health Insurance market size?
The global Short Term Health Insurance market is estimated at US$ 62.05 billion in 2025 (base year) and is projected to reach US$ 87.12 billion by 2032.
What growth rate is expected for the Short Term Health Insurance market through 2032?
The market is expected to grow at a CAGR of 5.0% from 2026 to 2032, expanding from US$ 62.05 billion in 2025 to US$ 87.12 billion in 2032, roughly 1.4 times its base-year value.
How is Short Term Health Insurance defined?
Short-term health insurance is an important segment of health insurance. According to regulatory definitions, it refers to health insurance with an insurance period of one year or less and no guaranteed renewal clause, mainly providing short-term medical protection for the insured. It mainly covers medical expenses such as outpatient and hospitalization caused by diseases and accidents for the insured, with flexible and diverse product designs, low insurance thresholds and affordable premiums.
How is the Short Term Health Insurance market segmented by type?
By type, the market is segmented into Reimbursement and Payment Method.
What are the key applications of Short Term Health Insurance?
Key applications covered include Individuals and Enterprises.
Which companies are profiled in the Short Term Health Insurance market report?
Key players profiled include UnitedHealth Group, Elevance Health, Centene Corporation, Cigna Group, Humana, CVS Health, Kaiser Permanente and Allianz, among 29 companies covered in total.
What geographies does the Short Term Health Insurance market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the main risks and barriers in the Short Term Health Insurance market?
Unlike long-term health insurance, which is tied to long-term coverage, short-term health insurance products are flexible and diverse in design, with low entry barriers and affordable premiums.
Who should buy the Short Term Health Insurance market report?
The report is intended for manufacturers and solution providers, distributors and end users in Individuals and Enterprises, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Short Term Health Insurance market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.